Somatostatin containing biodegradable microspheres prepared by a modified solvent evaporation method based on W/O/W-multiple emulsions

被引:74
作者
Herrmann, J
Bodmeier, R
机构
[1] FREE UNIV BERLIN,INST PHARM,D-12169 BERLIN,GERMANY
[2] UNIV TEXAS,COLL PHARM,AUSTIN,TX 78712
关键词
biodegradable polymer; microencapsulation; microspheres; peptide delivery system; poly(lactide); solvent evaporation method; somatostatin;
D O I
10.1016/0378-5173(95)04106-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Biodegradable polyester microspheres containing somatostatin acetate, a peptide drug, were prepared by a modified solvent evaporation method based on the formation of multiple W/O/W-emulsions. The resulting microspheres were characterized with respect to drug loading, encapsulation efficiency and morphological characteristics. Various methods for extracting the peptide from the microspheres were compared. Of all parameters investigated, factors affecting the properties of the primary W/O-emulsion, such as the phase volume ratio and total volume, were of major importance. A small volume of internal aqueous phase and an intermediate volume of organic solvent were favorable to achieve high drug encapsulation efficiencies. Replacing methylene chloride as an organic solvent with ethyl acetate reduced the encapsulation efficiency and resulted in more porous microspheres. Except for microspheres prepared with very low molecular weight polymers, the encapsulation efficiency was not affected by the polymer type (poly(L-lactide), poly(D,L-lactide), poly (D,L-lactide/glycolide)) and molecular weight. The preparation conditions substantially affected the morphology and porosity of the microspheres.
引用
收藏
页码:129 / 138
页数:10
相关论文
共 15 条
[1]   ENCAPSULATION OF WATER-SOLUBLE DRUGS BY A MODIFIED SOLVENT EVAPORATION METHOD .1. EFFECT OF PROCESS AND FORMULATION VARIABLES ON DRUG ENTRAPMENT [J].
ALEX, R ;
BODMEIER, R .
JOURNAL OF MICROENCAPSULATION, 1990, 7 (03) :347-355
[2]   PSEUDOEPHEDRINE HCL MICROSPHERES FORMULATED INTO AN ORAL SUSPENSION DOSAGE FORM [J].
BODMEIER, R ;
CHEN, H ;
TYLE, P ;
JAROSZ, P .
JOURNAL OF CONTROLLED RELEASE, 1991, 15 (01) :65-77
[3]  
CHEN H, 1992, THESIS U TEXAS AUSTI
[4]   CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES [J].
COHEN, S ;
YOSHIOKA, T ;
LUCARELLI, M ;
HWANG, LH ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :713-720
[5]  
CSERNUS VJ, 1990, INT J PEPT PROT RES, V35, P557
[6]  
Debesis E., 1982, PHARM TECH, V6, P120
[7]  
HERRMANN J, 1993, PHARMACEUT RES, V10, P233
[8]  
HEYA T, 1991, INT J PHARMACEUT, V69, P69
[9]  
KISSEL T, 1987, APV PAPERBACK, V17, P103
[10]  
Lee VHL, 1991, PEPTIDE PROTEIN DRUG